Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • ege
    Junior Member
    • Apr 2014
    • 3

    GATK preprocessed bam files for cufflinks?

    Hello all,
    I'm relatively new to rnaseq analysis. I've been reading a lot and currently trying to come up with a reliable pipeline.
    My question is, do you think it's ok to use GATK preprocessed(see below for details) bam files with Cufflinks?
    I'll summarize what I've done so far:
    I received raw, and clean reads(reads with adaptor sequences, reads in which the percentage of unknown bases (N) is greater than 10%, and reads in which the percentage of bases with quality value ≤ 5 are greater than 50% removed) freon the sequencing facility in fastq format.
    Because I didn't want to waste time with preprocessing the raw fq files, I used the clean fqs for alignments(after running FASTQC)
    I aligned the reads with Tophat2 using the hg19 references from Illumina iGenomes. I also had to use the --phred64-quals option because the quality scores showed up to be encoded by Illumina v1.5 on FastQC.
    My main objective is to perform differential expression and regulation analysis. Before that though, I'm now trying to call variants using GATK.(following the best practices article on Variant Calling on RNAseq posted on the GATK website.
    For preprocessing(using the accepted_hits.bam files produced by tophat)
    1-I added read group informations, sorted by coordinate, and marked duplicates
    2-used the new GATK tool named SplitNCigarReads to split reads into exon segments and hard-clip any sequences overhanging into the intronic regions
    3-Performed indel realignment and lastly base recalibration.
    Now I'm proceeding with variant calling but later this I'll also get to differential expression analysis.
    Back to my question; I do realize that the two processes are for vastly different purposes but do you think I could use final preprocessed bams instead of the original bams produced by tophat for cufflinks? Has anyone tried it/or anything similar?
    Other than that I'd also appreciate general suggestions regarding differential expression analysis. My sample sizes are vey low(a group of 4 vs a group of 3 samples) and because they're tumor samples I'm very concerned about the heterogeneity issue. Do you think i should stick with cufflinks or would you suggest some other tool?
    Sorry for the long post,
    Thanks in advance,
    -E
  • Brian Bushnell
    Super Moderator
    • Jan 2014
    • 2709

    #2
    You should use the original bam for RNA-seq expression analysis, otherwise information about splicing will be lost, and the number of fragments will look greater than it actually is, etc. Basically, it would just be wrong.

    Comment

    Latest Articles

    Collapse

    • mylaser
      Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by mylaser
      Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
      If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
      This guide explains everything you need to know about...
      07-11-2026, 01:13 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    15 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-07-2026, 11:05 AM
    0 responses
    33 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-02-2026, 11:08 AM
    0 responses
    31 views
    0 reactions
    Last Post SEQadmin2  
    Working...